UBS O'Connor’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.67M Sell
250,000
-100,000
-29% -$1.07M 0.08% 81
2025
Q3
$3.71M Buy
350,000
+100,000
+40% +$1.06M 0.12% 85
2025
Q2
$2.64M Buy
+250,000
New +$2.61M 0.07% 122

Other funds holding GPAT

UBS O'Connor's GPAT Position: Q4 2025 in Review

UBS O'Connor reduced its GP-Act III Acquisition Corp (GPAT) stake by 29% in Q4 2025, selling an estimated $1.07M and leaving 250,000 shares worth $2.67M. The position accounts for 0.08% of the portfolio, ranked #81.

UBS O'Connor first reported a position in GPAT in Q2 2025 and has held it in 3 quarters since. The position peaked at $3.71M in Q3 2025. 52 funds tracked by Wall St. Rank hold GPAT as of Q4 2025.

  • UBS O'Connor held 250,000 shares of GP-Act III Acquisition Corp worth $2.67M as of Q4 2025.
  • UBS O'Connor sold 100,000 GP-Act III Acquisition Corp shares in Q4 2025, an estimated $1.07M.
  • GP-Act III Acquisition Corp made up 0.08% of UBS O'Connor's portfolio in Q4 2025, its #81 holding.
  • UBS O'Connor first reported a position in GP-Act III Acquisition Corp in Q2 2025 and has held it in 3 quarters since.
  • UBS O'Connor's GP-Act III Acquisition Corp position peaked at $3.71M in Q3 2025.
  • 52 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q4 2025.

Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.